Wegovy patients saw 20% reduction in cardiovascular risks, drugmaker says

Deutschland Nachrichten Nachrichten

Wegovy patients saw 20% reduction in cardiovascular risks, drugmaker says
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 CBSNews
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 68%

Wegovy, one of a new class of drugs used for weight loss, reduced the risk of heart attacks in overweight adults in a large trial, according to its manufacturer.

Wednesday, Dr. Céline Gounder, a CBS News medical contributor and editor-at-large for public health at KFF Health News, said these results were better than expected.

"A 20% reduction in heart attacks and stroke from a weight loss medication — we've never seen that before with any approved weight loss medication," she said.Wegovy, a brand-name formulation of the GLP-1 receptor agonist semaglutide, received approval to treat adult obesity in 2021. An earlyThis latest study shows semaglutide can reduce patients' risks of experiencing cardiac events, which are more common in overweight and obese individuals.

Some insurers are paying tens of millions of dollars per month for semaglutide as more Americans are prescribed the medications, the Wall Street Journal

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

CBSNews /  🏆 87. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Popular Weight Loss Drug Wegovy Lowers Risk of Stroke and Heart Attack, Drugmaker SaysPopular Weight Loss Drug Wegovy Lowers Risk of Stroke and Heart Attack, Drugmaker SaysWeight Loss Drug Wegovy May Decrease Risk of Stroke and Heart Attack, Drugmaker Says
Weiterlesen »

Supply of Weight Loss Drug Wegovy Will Continue to be LimitedSupply of Weight Loss Drug Wegovy Will Continue to be LimitedNovo Nordisk, manufacturer of the weight loss drug Wegovy, said Thursday that it will continue to restrict supplies of starter doses of the drug in the United States. This restriction will likely continue into next year.
Weiterlesen »

Novo Nordisk's Wegovy faces supply constraints as demand surgesNovo Nordisk's Wegovy faces supply constraints as demand surgesNovo Nordisk said lower-dose strengths of Wegovy will be limited as it tries to ramp up production to meet the surge in demand for the weight loss drug.
Weiterlesen »

Clear the Shelters 2023: Help NBC 7 & Telemundo 20 adopt pets from San Diego sheltersClear the Shelters 2023: Help NBC 7 & Telemundo 20 adopt pets from San Diego sheltersThroughout the month of August, San Diegans can bring home a new furry friend for this year’s Clear The Shelters — NBCUniversal Local’s nationwide pet adoption and donation campaign.
Weiterlesen »

20 Best Easter Eggs In Edgar Wright's Cornetto Trilogy Movies20 Best Easter Eggs In Edgar Wright's Cornetto Trilogy MoviesEdgar Wright’s Three Flavors Cornetto trilogy is chock-full of references, cameos, and Easter eggs. Here are the 20 best across all three films.
Weiterlesen »

Texans Takeaways: Texans open with 20-9 win over Patriots in preseason debutTexans Takeaways: Texans open with 20-9 win over Patriots in preseason debut.Texans Takeaways and Interviews from DeMeco Ryans and QB C.J. Stroud plus our KPRC 2 Texans Insider Aaron Wilson (AaronWilson_NFL ) 1 on 1 in the Lockerroom with Jalen Pitre (JalenPitre1 ) after the 20-9 win over the Patriots.
Weiterlesen »



Render Time: 2025-02-28 06:32:12